Company's Solutions

ATLASense developed REPHAEL.

REPHAEL is a multi-indication platform, the next generation of remote health surveillance systems

It is based on a single data source reusable chest-worn device, the PolyMonitor.

Why does the world need a new RPM device?

1. Current treatments are only reactive
2. Hospitals are losing money
3. Medical wearables are clinically limited, mainly for acute conditions, and expensive…
4. For example, the standard of care respiratory monitors alert only on already in-failure conditions requiring hospitalization!

There is NO EARLY WARNING, no preventive-care

We are different because:

REPHAEL is an ICU-grade, designed to continuously follow up on multiple co-morbidities and chronically ill populations both in the hospital and at home.

Affordable - Our end-to-end solution has the lowest cost of use compared to any alternative
ATLASense is the only company to develop a unique biomarker for EARLY WARNING on respiratory failure three days ahead!

So, How do we do it?

The reusable PolyMonitor generates 15 signals simultaneously every fraction of a second and streams them to our cloud server.

Our AI analytic SW analyzes unique biomarkers of early warnings and enables over 50 indications.

Our Telemetry dashboard in the nurses' pocket for the first time lets nurses prioritize the work according to the patient's condition.

Prominent Case Study

Remote Health Surveillance - Early warning of respiratory insufficiency

• The standard of care respiratory monitors alerts only on already in-failure conditions such as SpO2, requiring hospitalization!
• Currently, There is NO EARLY WARNING, and no preventive care.

ATLASense is the only company to develop a unique biomarker for EARLY WARNING on respiratory failure three days ahead!